drugset / Trial / NCT03167138

Micro-Fragmented Adipose Tissue (Lipogems®) Injection for Chronic Shoulder Pain in Persons With Spinal Cord Injury

NCT03167138 ↗

Phase 0 Unknown 10 enrolled Kessler Foundation
NaSingle-groupOpen-labelTreatment

Summary

Rotator cuff disease (i.e., rotator cuff tendinopathy or tear) is a common cause of shoulder pain in persons with chronic spinal cord injury (SCI). It usually resolves with non-operative treatments such as pharmacological agents and physical therapy; however, when this fails, rotator cuff surgery may be the only option. Autologous adipose tissue injection has recently emerged as a promising new treatment for joint pain and soft tissue injury. Adipose can be used to provide cushioning and filling of structural defects and has been shown to have an abundance of bioactive elements and regenerative perivascular cells (pericytes). The purpose of this study is to explore the safety and efficacy of autologous, micro-fragmented adipose tissue (Lipogems®) injection under ultrasound guidance for chronic shoulder pain in persons with SCI.

Timeline

Start
2017-07-14
Primary completion
2019-09-06
Completion
2020-02-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous micro-fragmented adipose tissue Unknown 6 ml Other